Abnormal expression of HADH, an enzyme of fatty acid oxidation, affects tumor development and prognosis (Review)
- Authors:
- Xiaoqing Wang
- Honghao Song
- Junyu Liang
- Yang Jia
- Yongfei Zhang
-
Affiliations: Department of Pediatric Surgery, Shandong Provincial Hospital, Shandong University, Jinan, Shandong 250021, P.R. China, Department of Thoracic Surgery, Shandong Provincial Hospital, Shandong University, Jinan, Shandong 250021, P.R. China, Post‑doctoral Research Station of Clinical Medicine, Liaocheng People's Hospital, Jinan, Shandong 252004, P.R. China, Department of Dermatology, The First Affiliated Hospital of Shandong First Medical University, Jinan, Shandong 250021, P.R. China - Published online on: October 13, 2022 https://doi.org/10.3892/mmr.2022.12871
- Article Number: 355
-
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
|
Hanahan D and Weinberg RA: Hallmarks of cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Tennant DA, Durán RV and Gottlieb E: Targeting metabolic transformation for cancer therapy. Nat Rev Cancer. 10:267–277. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Madhusudhan N, Hu B, Mishra P, Calva-Moreno JF, Patel K, Boriack R, Ready JM and Nijhawan D: Target discovery of selective non-small-cell lung cancer toxins reveals inhibitors of mitochondrial complex I. ACS Chem Biol. 15:158–170. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Wang M, Han J, Xing H, Zhang H, Li Z, Liang L, Li C, Dai S, Wu M, Shen F and Yang T: Dysregulated fatty acid metabolism in hepatocellular carcinoma. Hepat Oncol. 3:241–251. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Mancini R, Noto A, Pisanu ME, De Vitis C, Maugeri-Saccà M and Ciliberto G: Metabolic features of cancer stem cells: The emerging role of lipid metabolism. Oncogene. 37:2367–2378. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Xia C, Fu Z, Battaile KP and Kim JP: Crystal structure of human mitochondrial trifunctional protein, a fatty acid β-oxidation metabolon. Proc Natl Acad Sci USA. 116:6069–6074. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Liang K, Li N, Wang X, Dai J, Liu P, Wang C, Chen XW, Gao N and Xiao J: Cryo-EM structure of human mitochondrial trifunctional protein. Proc Natl Acad Sci USA. 115:7039–7044. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
El-Fakhri M and Middleton B: The existence of an inner-membrane-bound, long acyl-chain-specific 3-hydroxyacyl-CoA dehydrogenase in mammalian mitochondria. Biochim Biophys Acta. 713:270–279. 1982. View Article : Google Scholar : PubMed/NCBI | |
|
L IJ, Ruiter JP, Hoovers JM, Jakobs ME and Wanders RJ: Common missense mutation G1528C in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Characterization and expression of the mutant protein, mutation analysis on genomic DNA and chromosomal localization of the mitochondrial trifunctional protein alpha subunit gene. J Clin Invest. 98:1028–1033. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Ushikubo S, Aoyama T, Kamijo T, Wanders RJ, Rinaldo P, Vockley J and Hashimoto T: Molecular characterization of mitochondrial trifunctional protein deficiency: Formation of the enzyme complex is important for stabilization of both alpha- and beta-subunits. Am J Hum Genet. 58:979–988. 1996.PubMed/NCBI | |
|
Schwab KO, Ensenauer R, Matern D, Uyanik G, Schnieders B, Wanders RA and Lehnert W: Complete deficiency of mitochondrial trifunctional protein due to a novel mutation within the beta-subunit of the mitochondrial trifunctional protein gene leads to failure of long-chain fatty acid beta-oxidation with fatal outcome. Eur J Pediatr. 162:90–95. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Yang J, Yuan D, Tan X, Zeng Y, Tang N, Chen D, Tan J, Cai R, Huang J and Yan T: Analysis of a family with mitochondrial trifunctional protein deficiency caused by HADHA gene mutations. Mol Med Rep. 25:472022. View Article : Google Scholar : PubMed/NCBI | |
|
Taïb B, Aboussalah AM, Moniruzzaman M, Chen S, Haughey NJ, Kim SF and Ahima RS: Lipid accumulation and oxidation in glioblastoma multiforme. Sci Rep. 9:195932019. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang N, Xie B, Xiao W, Fan M, Xu S, Duan Y, Hamsafar Y, Evans AC, Huang J, Zhou W, et al: Fatty acid oxidation fuels glioblastoma radioresistance with CD47-mediated immune evasion. Nat Commun. 13:15112022. View Article : Google Scholar : PubMed/NCBI | |
|
Yang K and Rich JN: A delicate initiation: Lipolysis of lipid droplets fuels glioblastoma. Mol Cell. 81:2686–2687. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Zhang T, Li C, Guo J, Xu B and Xue L: Telmisartan attenuates human glioblastoma cells proliferation and oncogenicity by inducing the lipid oxidation. Asia Pac J Clin Oncol. 18:217–223. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Marur S and Forastiere AA: Head and neck squamous cell carcinoma: Update on epidemiology, diagnosis, and treatment. Mayo Clin Proc. 91:386–396. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Shetty SR, Babu S, Kumari S, Shetty P, Hegde S and Castelino R: Status of salivary lipid peroxidation in oral cancer and precancer. Indian J Med Paediatr Oncol. 35:156–158. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Malik UU, Siddiqui IA, Hashim Z and Zarina S: Measurement of serum paraoxonase activity and MDA concentrations in patients suffering with oral squamous cell carcinoma. Clin Chim Acta. 430:38–42. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Kaur J, Politis C and Jacobs R: Salivary 8-hydroxy-2-deoxyguanosine, malondialdehyde, vitamin C, and vitamin E in oral pre-cancer and cancer: Diagnostic value and free radical mechanism of action. Clin Oral Investig. 20:315–319. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Huang ZD, Yao YY, Chen TY, Zhao YF, Zhang C and Niu YM: Construction of prognostic risk prediction model of oral squamous cell carcinoma based on nine survival-associated metabolic genes. Front Physiol. 12:6097702021. View Article : Google Scholar : PubMed/NCBI | |
|
Zemanova M, Vecka M, Petruželka L, Staňková B, Žák A and Zeman M: Plasma phosphatidylcholines fatty acids in men with squamous cell esophageal cancer: Chemoradiotherapy improves abnormal profile. Med Sci Monit. 22:4092–4099. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Zuijdgeest-van Leeuwen SD, van der Heijden MS, Rietveld T, van den Berg JW, Tilanus HW, Burgers JA, Wilson JH and Dagnelie PC: Fatty acid composition of plasma lipids in patients with pancreatic, lung and oesophageal cancer in comparison with healthy subjects. Clin Nutr. 21:225–230. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Wang AH, Liu Y, Wang B, He YX, Fang YX and Yan YP: Epidemiological studies of esophageal cancer in the era of genome-wide association studies. World J Gastrointest Pathophysiol. 5:335–343. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Abbas G and Krasna M: Overview of esophageal cancer. Ann Cardiothorac Surg. 6:131–136. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Wang F, Zhang L, Xu Y, Xie Y and Li S: Comprehensive analysis and identification of key driver genes for distinguishing between esophageal adenocarcinoma and squamous cell carcinoma. Front Cell Dev Biol. 9:6761562021. View Article : Google Scholar : PubMed/NCBI | |
|
Chen D, Zhang Y, Wang W, Chen H, Ling T, Yang R, Wang Y, Duan C, Liu Y, Guo X, et al: Identification and characterization of robust hepatocellular carcinoma prognostic subtypes based on an integrative metabolite-protein interaction network. Adv Sci (Weinh). 8:e21003112021. View Article : Google Scholar : PubMed/NCBI | |
|
Tanaka M, Masaki Y, Tanaka K, Miyazaki M, Kato M, Sugimoto R, Nakamura K, Aishima S, Shirabe K, Nakamuta M, et al: Reduction of fatty acid oxidation and responses to hypoxia correlate with the progression of de-differentiation in HCC. Mol Med Rep. 7:365–370. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Khare T, Khare S, Angdisen JJ, Zhang Q, Stuckel A, Mooney BP, Ridenhour SE, Gitan RS, Hammoud GM and Ibdah JA: Defects in long-chain 3-hydroxy acyl-CoA dehydrogenase lead to hepatocellular carcinoma: A novel etiology of hepatocellular carcinoma. Int J Cancer. 147:1461–1473. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Y, Lu LL, Wen D, Liu DL, Dong LL, Gao DM, Bian XY, Zhou J, Fan J and Wu WZ: MiR-612 regulates invadopodia of hepatocellular carcinoma by HADHA-mediated lipid reprogramming. J Hematol Oncol. 13:122020. View Article : Google Scholar : PubMed/NCBI | |
|
Shi Q, Liu Y, Lu M, Lei QY, Chen Z, Wang L and He X: A pathway-guided strategy identifies a metabolic signature for prognosis prediction and precision therapy for hepatocellular carcinoma. Comput Biol Med. 144:1053762022. View Article : Google Scholar : PubMed/NCBI | |
|
Hao X, Ren Y, Feng M, Wang Q and Wang Y: Metabolic reprogramming due to hypoxia in pancreatic cancer: Implications for tumor formation, immunity, and more. Biomed Pharmacother. 141:1117982021. View Article : Google Scholar : PubMed/NCBI | |
|
Di Carlo C, Brandi J and Cecconi D: Pancreatic cancer stem cells: Perspectives on potential therapeutic approaches of pancreatic ductal adenocarcinoma. World J Stem Cells. 10:172–182. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Di Carlo C, Sousa BC, Manfredi M, Brandi J, Dalla Pozza E, Marengo E, Palmieri M, Dando I, Wakelam MJO, Lopez-Clavijo AF and Cecconi D: Integrated lipidomics and proteomics reveal cardiolipin alterations, upregulation of HADHA and long chain fatty acids in pancreatic cancer stem cells. Sci Rep. 11:132972021. View Article : Google Scholar : PubMed/NCBI | |
|
Chen L, Vasoya RP, Toke NH, Parthasarathy A, Luo S, Chiles E, Flores J, Gao N, Bonder EM, Su X and Verzi MP: HNF4 regulates fatty acid oxidation and is required for renewal of intestinal stem cells in mice. Gastroenterology. 158:985–999.e9. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Voloshanenko O, Schwartz U, Kranz D, Rauscher B, Linnebacher M, Augustin I and Boutros M: β-catenin-independent regulation of Wnt target genes by RoR2 and ATF2/ATF4 in colon cancer cells. Sci Rep. 8:31782018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou Y, Li X, Guan A, Zhou H, Zhu Y, Wang R and Li R: EPHX2 inhibits colon cancer progression by promoting fatty acid degradation. Front Oncol. 12:8707212022. View Article : Google Scholar : PubMed/NCBI | |
|
Nassar D and Blanpain C: Cancer stem cells: Basic concepts and therapeutic implications. Annu Rev Pathol. 11:47–76. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Du Z, Zhang X, Gao W and Yang J: Differentially expressed genes PCCA, ECHS1, and HADH are potential prognostic biomarkers for gastric cancer. Sci Prog. 104:3685042110113442021. View Article : Google Scholar : PubMed/NCBI | |
|
Moehler M, Baltin CT, Ebert M, Fischbach W, Gockel I, Grenacher L, Hölscher AH, Lordick F, Malfertheiner P, Messmann H, et al: International comparison of the German evidence-based S3-guidelines on the diagnosis and multimodal treatment of early and locally advanced gastric cancer, including adenocarcinoma of the lower esophagus. Gastric Cancer. 18:550–563. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Shen C, Song YH, Xie Y, Wang X, Wang Y, Wang C, Liu S, Xue SL, Li Y, Liu B, et al: Downregulation of HADH promotes gastric cancer progression via Akt signaling pathway. Oncotarget. 8:76279–76289. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Gao T, Li M, Mu G, Hou T, Zhu WG and Yang Y: PKCζ phosphorylates SIRT6 to mediate fatty acid β-oxidation in colon cancer cells. Neoplasia. 21:61–73. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Croner RS, Sevim M, Metodiev MV, Jo P, Ghadimi M, Schellerer V, Brunner M, Geppert C, Rau T, Stürzl M, et al: Identification of predictive markers for response to neoadjuvant chemoradiation in rectal carcinomas by proteomic isotope coded protein label (ICPL) analysis. Int J Mol Sci. 17:2092016. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu Y, Lu H, Zhang D, Li M, Sun X, Wan L, Yu D, Tian Y, Jin H, Lin A, et al: Integrated analyses of multi-omics reveal global patterns of methylation and hydroxymethylation and screen the tumor suppressive roles of HADHB in colorectal cancer. Clin Epigenetics. 10:302018. View Article : Google Scholar : PubMed/NCBI | |
|
Peng WF, Bai F, Shao K, Shen LS, Li HH and Huang S: The key genes underlying pathophysiology association between the type 2-diabetic and colorectal cancer. J Cell Physiol. 233:8551–8557. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Hu TT, Yang JW, Yan Y, Chen YY, Xue HB, Xiang YQ and Ye LC: Detection of genes responsible for cetuximab sensitization in colorectal cancer cells using CRISPR-Cas9. Biosci Rep. 40:BSR202011252020. View Article : Google Scholar : PubMed/NCBI | |
|
Ren J, Feng J, Song W, Wang C, Ge Y and Fu T: Development and validation of a metabolic gene signature for predicting overall survival in patients with colon cancer. Clin Exp Med. 20:535–544. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Krause JR: WHO classification of tumours of haematopoietic and lymphoid tissues: An overview. Crit Values. 2:30–32. 2009. View Article : Google Scholar | |
|
Yamamoto K, Abe S, Honda A, Hashimoto J, Aizawa Y, Ishibashi S, Takemura T, Hanagata N, Yamamoto M, Miura O, et al: Fatty acid beta oxidation enzyme HADHA is a novel potential therapeutic target in malignant lymphoma. Lab Invest. 100:353–362. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Sekine Y, Yamamoto K, Kurata M, Honda A, Onishi I, Kinowaki Y, Kawade G, Watabe S, Nomura S, Fukuda S, et al: HADHB, a fatty acid beta-oxidation enzyme, is a potential prognostic predictor in malignant lymphoma. Pathology. 54:286–293. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Hensley CT, Faubert B, Yuan Q, Lev-Cohain N, Jin E, Kim J, Jiang L, Ko B, Skelton R, Loudat L, et al: Metabolic heterogeneity in human lung tumors. Cell. 164:681–694. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Amoedo ND, Sarlak S, Obre E, Esteves P, Bégueret H, Kieffer Y, Rousseau B, Dupis A, Izotte J, Bellance N, et al: Targeting the mitochondrial trifunctional protein restrains tumor growth in oxidative lung carcinomas. J Clin Invest. 131:e1330812021. View Article : Google Scholar : PubMed/NCBI | |
|
Ginsburg O, Bray F, Coleman MP, Vanderpuye V, Eniu A, Kotha SR, Sarker M, Huong TT, Allemani C, Dvaladze A, et al: The global burden of women's cancers: A grand challenge in global health. Lancet. 389:847–860. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Pauwels EK and Kairemo K: Fatty acid facts, part II: Role in the prevention of carcinogenesis, or, more fish on the dish? Drug News Perspect. 21:504–510. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou Z, Zhou J and Du Y: Estrogen receptor beta interacts and colocalizes with HADHB in mitochondria. Biochem Biophys Res Commun. 427:305–308. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou Z, Zhou J and Du Y: Estrogen receptor alpha interacts with mitochondrial protein HADHB and affects beta-oxidation activity. Mol Cell Proteomics. 11:M111.011056. 2012. View Article : Google Scholar | |
|
Mamtani M and Kulkarni H: Association of HADHA expression with the risk of breast cancer: Targeted subset analysis and meta-analysis of microarray data. BMC Res Notes. 5:252012. View Article : Google Scholar : PubMed/NCBI | |
|
Ji C, Hu J, Wang X, Zheng W, Deng X, Song H, Yu Y, Luo Q, Hua K, Zhou X and Fang L: Hsa_circ_0053063 inhibits breast cancer cell proliferation via hsa_circ_0053063/hsa-miR-330-3p/PDCD4 axis. Aging (Albany NY). 13:9627–9645. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Massari F, Ciccarese C, Santoni M, Brunelli M, Piva F, Modena A, Bimbatti D, Fantinel E, Santini D, Cheng L, et al: Metabolic alterations in renal cell carcinoma. Cancer Treat Rev. 41:767–776. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Du W, Zhang L, Brett-Morris A, Aguila B, Kerner J, Hoppel CL, Puchowicz M, Serra D, Herrero L, Rini BI, et al: HIF drives lipid deposition and cancer in ccRCC via repression of fatty acid metabolism. Nat Commun. 8:17692017. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu Y, Wang HK, Zhang HL, Yao XD, Zhang SL, Dai B, Shen YJ, Liu XH, Zhou LP and Ye DW: Visceral obesity and risk of high grade disease in clinical t1a renal cell carcinoma. J Urol. 189:447–453. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Gebhard RL, Clayman RV, Prigge WF, Figenshau R, Staley NA, Reesey C and Bear A: Abnormal cholesterol metabolism in renal clear cell carcinoma. J Lipid Res. 28:1177–1184. 1987. View Article : Google Scholar : PubMed/NCBI | |
|
Wettersten HI, Hakimi AA, Morin D, Bianchi C, Johnstone ME, Donohoe DR, Trott JF, Aboud OA, Stirdivant S, Neri B, et al: Grade-dependent metabolic reprogramming in kidney cancer revealed by combined proteomics and metabolomics analysis. Cancer Res. 75:2541–2552. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao Z, Lu J, Han L, Wang X, Man Q and Liu S: Prognostic significance of two lipid metabolism enzymes, HADHA and ACAT2, in clear cell renal cell carcinoma. Tumour Biol. 37:8121–8130. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Liu S, Liu X, Wu F, Zhang X, Zhang H, Gao D, Bi D, Qu H, Ge J, Xu Y and Zhao Z: HADHA overexpression disrupts lipid metabolism and inhibits tumor growth in clear cell renal cell carcinoma. Exp Cell Res. 384:1115582019. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao Z, Liu Y, Liu Q, Wu F, Liu X, Qu H, Yuan Y, Ge J, Xu Y and Wang H: The mRNA expression signature and prognostic analysis of multiple fatty acid metabolic enzymes in clear cell renal cell carcinoma. J Cancer. 10:6599–6607. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Ramburan A, Chetty R, Hadley GP, Naidoo R and Govender D: Microsatellite analysis of the DCC gene in nephroblastomas: Pathologic correlations and prognostic implications. Mod Pathol. 17:89–95. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Wu X, Feng R, Wang X, Guo F and Liu W: Roles of hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha, a lipid metabolism enzyme, in Wilms tumor patients. J Cancer Res Ther. 17:1281–1285. 2021.PubMed/NCBI | |
|
Wang X, Du G, Wu Y, Zhang Y, Guo F, Liu W and Wu R: Association between different levels of lipid metabolism-related enzymes and fatty acid synthase in Wilms' tumor. Int J Oncol. 56:568–580. 2020.PubMed/NCBI | |
|
Aoyama T, Wakui K, Orii KE, Hashimoto T and Fukushima Y: Fluorescence in situ hybridization mapping of the alpha and beta subunits (HADHA and HADHB) of human mitochondrial fatty acid beta-oxidation multienzyme complex to 2p23 and their evolution. Cytogenet Cell Genet. 79:221–224. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Maeyashiki C, Oshima S, Otsubo K, Kobayashi M, Nibe Y, Matsuzawa Y, Onizawa M, Nemoto Y, Nagaishi T, Okamoto R, et al: HADHA, the alpha subunit of the mitochondrial trifunctional protein, is involved in long-chain fatty acid-induced autophagy in intestinal epithelial cells. Biochem Biophys Res Commun. 484:636–641. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Soliman E, Elhassanny AEM, Malur A, McPeek M, Bell A, Leffler N, Van Dross R, Jones JL, Malur AG and Thomassen MJ: Impaired mitochondrial function of alveolar macrophages in carbon nanotube-induced chronic pulmonary granulomatous disease. Toxicology. 445:1525982020. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang H, Chen H, Wan P and Chen N: Decreased expression of HADH is related to poor prognosis and immune infiltration in kidney renal clear cell carcinoma. Genomics. 113:3556–3564. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Zhelev Z, Aoki I, Lazarova D, Vlaykova T, Higashi T and Bakalova R: A ‘weird’ mitochondrial fatty acid oxidation as a metabolic ‘secret’ of cancer. Oxid Med Cell Longev. 2022:23395842022. View Article : Google Scholar : PubMed/NCBI | |
|
Zeng W, Liu P, Pan W, Singh SR and Wei Y: Hypoxia and hypoxia inducible factors in tumor metabolism. Cancer Lett. 356:263–267. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Denko NC: Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat Rev Cancer. 8:705–713. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Milane L, Duan Z and Amiji M: Role of hypoxia and glycolysis in the development of multi-drug resistance in human tumor cells and the establishment of an orthotopic multi-drug resistant tumor model in nude mice using hypoxic pre-conditioning. Cancer Cell Int. 11:32011. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang K, Han ES, Dellinger TH, Lu J, Nam S, Anderson RA, Yim JH and Wen W: Cinnamon extract reduces VEGF expression via suppressing HIF-1α gene expression and inhibits tumor growth in mice. Mol Carcinog. 56:436–446. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Yin J, Miyazaki K, Shaner RL, Merrill AH Jr and Kannagi R: Altered sphingolipid metabolism induced by tumor hypoxia-new vistas in glycolipid tumor markers. FEBS Lett. 584:1872–1878. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Ezzeddini R, Taghikhani M, Salek Farrokhi A, Somi MH, Samadi N, Esfahani A and Rasaee MJ: Downregulation of fatty acid oxidation by involvement of HIF-1α and PPARγ in human gastric adenocarcinoma and related clinical significance. J Physiol Biochem. 77:249–260. 2021. View Article : Google Scholar : PubMed/NCBI |
